Filtered By:
Specialty: Cancer & Oncology
This page shows you your search results in order of relevance. This is page number 18.
Order by Relevance | Date
Total 1099 results found since Jan 2013.
The incidence and risk of cardiovascular events associated with immune checkpoint inhibitors in Asian populations
CONCLUSIONS: Among Asians, immune checkpoint inhibitors were associated with an increased risk of major adverse cardiovascular events, particularly ischemic stroke and pulmonary embolism.PMID:36208180 | DOI:10.1093/jjco/hyac150
Source: Clinical Lung Cancer - October 8, 2022 Category: Cancer & Oncology Authors: Cho-Han Chiang Cho-Hung Chiang Kevin Sheng-Kai Ma Yuan Ping Hsia Yu-Wen Lee Han-Ru Wu Cho-Hsien Chiang Chun-Yu Peng James Cheng-Chung Wei Her-Shyong Shiah Cheng-Ming Peng Tomas G Neilan Source Type: research
The Development of Neuroimaging Biomarkers for Cognitive Decline in Sickle Cell Disease
Sickle cell disease (SCD) is complicated by neurologic complications including vasculopathy, hemorrhagic or ischemic overt stroke, silent cerebral infarcts and cognitive dysfunction. Patients with SCD, even in the absence of vasculopathy or stroke, have experience cognitive dysfunction that progresses with age. Transcranial Doppler ultrasound and structural brain MRI are currently used for primary and secondary stroke prevention, but laboratory or imaging biomarkers do not currently exist that are specific to the risk of cognitive dysfunction in patients with SCD. Recent investigations have used advanced MR sequences asses...
Source: Hematology/Oncology Clinics of North America - November 16, 2022 Category: Cancer & Oncology Authors: Kristie Ramos, Kristin P. Guilliams, Melanie E. Fields Source Type: research
Comparative Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin Among Adults With Cancer and Atrial Fibrillation
CONCLUSIONS: Older adults with cancer and atrial fibrillation exposed to DOACs had similar risks of stroke and systemic embolism and major bleeding as those exposed to warfarin. Relative to warfarin, DOAC use was associated with a similar risk of cardiovascular death and a lower risk of all-cause death.PMID:36453260 | DOI:10.1161/CIRCOUTCOMES.122.008951
Source: Cancer Control - December 1, 2022 Category: Cancer & Oncology Authors: Hemalkumar B Mehta Huijun An Shirin Ardeshirrouhanifard Mukaila A Raji G Caleb Alexander Jodi B Segal Source Type: research
Multi-omics reveals specific host metabolism-microbiome associations in intracerebral hemorrhage
In conclusion, microbiome-related metabolites in ICH patients was associated with the severity of ICH, the microbiota-host co-metabolites may be a potential may be potential therapeutic targets.PMID:36619742 | PMC:PMC9813413 | DOI:10.3389/fcimb.2022.999627
Source: Cancer Control - January 9, 2023 Category: Cancer & Oncology Authors: Lei Chen Sai Wang Yupeng Zhang Ye Li Xiangbin Zhang Junyi Ma Xuelun Zou TianXing Yao Si Li Junyou Chen Huifang Zhou Lianxu Wu Yanhong Zhou Le Zhang Source Type: research
Dietary inflammatory index and cardiovascular disease risk in Hispanic women from the Women's Health Initiative
CONCLUSION: Among postmenopausal Hispanic women with overweight, greater adherence to pro-inflammatory diets was associated with higher risk of CVD. Additional research is needed to understand how to promote long-term heart-healthy dietary habits to reduce inflammation and prevent CVD in at-risk Hispanic women.PMID:36631866 | DOI:10.1186/s12937-023-00838-9
Source: Cancer Control - January 11, 2023 Category: Cancer & Oncology Authors: Monica D Zuercher Danielle J Harvey Margarita Santiago-Torres Lauren E Au Nitin Shivappa Aladdin H Shadyab Matthew Allison Linda Snetselaar Buyun Liu John A Robbins James R H ébert Lorena Garcia Source Type: research
Nuts and Cardiovascular Disease Outcomes: A Review of the Evidence and Future Directions
Nutrients. 2023 Feb 11;15(4):911. doi: 10.3390/nu15040911.ABSTRACTNuts are nutrient-rich foods that contain many bioactive compounds that are beneficial for cardiovascular health. Higher consumption of nuts has been associated with a reduced risk of several cardiovascular diseases (CVD) in prospective cohort studies, including a 19% and 25% lower risk of CVD incidence and mortality, respectively, and a 24% and 27% lower risk of coronary heart disease incidence and mortality, respectively. An 18% lower risk of stroke mortality, a 15% lower risk of atrial fibrillation, and a 19% lower risk of total mortality have also been o...
Source: Cancer Control - February 25, 2023 Category: Cancer & Oncology Authors: Andrea J Glenn Dagfinn Aune Heinz Freisling Noushin Mohammadifard Cyril W C Kendall Jordi Salas-Salvad ó David J A Jenkins Frank B Hu John L Sievenpiper Source Type: research
Outcomes of Early Rhythm Control Therapy in Patients With Atrial Fibrillation and a High Comorbidity Burden in Large Real-World Cohorts
CONCLUSIONS: ERC is safe and may be more favorable in a population-based sample of patients with high a comorbidity burden (CHA2DS2-VASc score ≥4).PMID:36942567 | DOI:10.1161/CIRCEP.122.011585
Source: Cancer Control - March 21, 2023 Category: Cancer & Oncology Authors: Jannis Dickow Shinwan Kany Victor Roth Cardoso Patrick T Ellinor Georgios V Gkoutos Holly K Van Houten Paulus Kirchhof Andreas Metzner Peter A Noseworthy Xiaoxi Yao Andreas Rillig Source Type: research
Impact of Cardiovascular Disease on the Death Certificate Diagnosis of Heart Failure, Ischemic Heart Disease, and Cerebrovascular Disease - The Japan Public Health Center-Based Prospective Study
CONCLUSIONS: HF as the UCD was partly explained by CVD. The data imply that most HF deaths reported in vital statistics may be associated with underlying causes other than CVD.PMID:36948630 | DOI:10.1253/circj.CJ-22-0805
Source: Cancer Control - March 22, 2023 Category: Cancer & Oncology Authors: Isao Saito Kazumasa Yamagishi Yoshihiro Kokubo Hiroshi Yatsuya Hiroyasu Iso Norie Sawada Manami Inoue Shoichiro Tsugane Source Type: research
Long-term Cardiovascular Risks of Gonadotropin-releasing Hormone Agonists and Antagonists: A Population-based Cohort Study
CONCLUSIONS: GnRH antagonists may be associated with higher long-term, but not short-term, cardiovascular risks than agonists in Asian patients with PCa, particularly in those without known cardiovascular risk factors.PMID:37031076 | DOI:10.1016/j.clon.2023.03.014
Source: Clinical Prostate Cancer - April 8, 2023 Category: Cancer & Oncology Authors: J S K Chan Y H A Lee J M H Hui K Liu E C Dee K Ng P Tang G Tse C F Ng Source Type: research
Late-onset vascular complications of radiotherapy for primary brain tumors: a case –control and cross-sectional analysis
ConclusionsStroke prevalence is increased in long-surviving PBT patients treated with cranial RT.Implications for cancer survivorsCV events are frequent in long survivors of PBT treated with cerebral RT. We propose a check list to guide management of late CV complications in adults treated with RT for PBT.
Source: Journal of Cancer Survivorship - May 5, 2023 Category: Cancer & Oncology Source Type: research
Evidence That Increasing Serum 25(OH)D Concentrations to 30 ng/mL in the Kingdom of Saudi Arabia and the United Arab Emirates Could Greatly Improve Health Outcomes
Biomedicines. 2023 Mar 23;11(4):994. doi: 10.3390/biomedicines11040994.ABSTRACTAccumulating evidence supports the potential protective effects of vitamin D against chronic diseases such as Alzheimer's disease, autoimmune diseases, cancers, cardiovascular disease (ischaemic heart disease and stroke), type 2 diabetes, hypertension, chronic kidney disease, stroke, and infectious diseases such as acute respiratory tract diseases, COVID-19, influenza, and pneumonia, as well as adverse pregnancy outcomes. The respective evidence is based on ecological and observational studies, randomized controlled trials, mechanistic studies, ...
Source: Cancer Control - May 16, 2023 Category: Cancer & Oncology Authors: William B Grant Fatme Al Anouti Barbara J Boucher Hana M A Fakhoury Meis Moukayed Stefan Pilz Nasser M Al-Daghri Source Type: research
Systematic review evaluating cardiovascular events of the 5-alpha reductase inhibitor - Dutasteride.
CONCLUSION: We did not find consistent evidence of a significant association between dutasteride therapy and the risk of cardiovascular adverse events.
PMID: 23815285 [PubMed - as supplied by publisher]
Source: Clinical Prostate Cancer - July 1, 2013 Category: Cancer & Oncology Authors: Loke YK, Ho R, Smith M, Wong O, Sandhu M, Sage W, Singh S Tags: J Clin Pharm Ther Source Type: research
"Quitting Smoking Will Benefit Your Health": The Evolution of Clinician Messaging to Encourage Tobacco Cessation.
In conclusion, instead of using loss-framed statements like "Smoking will harm your health by causing problems like lung and other cancers, heart disease, and stroke," as a general rule, physicians should use gain-framed statements like "Quitting smoking will benefit your health by preventing problems like lung and other cancers, heart disease, and stroke." Clin Cancer Res; 20(2); 1-9. ©2014 AACR.
PMID: 24436474 [PubMed - as supplied by publisher]
Source: Clinical Cancer Research - January 16, 2014 Category: Cancer & Oncology Authors: Toll BA, Rojewski AM, Duncan LR, Latimer-Cheung AE, Fucito LM, Boyer JL, O'Malley SS, Salovey P, Herbst RS Tags: Clin Cancer Res Source Type: research
